Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial

NCT05782777 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

4310

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation

Interventions

DRUG: ezetimibe/high-intensity statin combination therapy (ezetimibe 10mg plus atoravastatin 40mg)
DRUG: high-intensity statin monotherapy (atoravastatin 40mg)

Sponsor

Yonsei University